[1] |
Amaravadi RK, Lippincott-Schwartz J, Yin XM , et al. Prin-ciples and current strategies for targeting autophagy for can-cer treatment[J]. Clin Cancer Res, 2011,17(4):654-666.
doi: 10.1158/1078-0432.CCR-10-2634
URL
pmid: 21325294
|
[2] |
Lai K, Killingsworth M, Yong J , et al. Specific localization of LC3B in autophagosome: a correlative labelling study with nanoparticle in oral squamous cell carcinoma[J]. Exp Mol Pathol, 2017,102(3):422-427.
doi: 10.1016/j.yexmp.2017.05.007
URL
pmid: 28506764
|
[3] |
Ladoire S, Penault-Llorca F, Senovilla L , et al. Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer[J]. Autophagy, 2015,11(10):1878-1890.
doi: 10.1080/15548627.2015.1082022
URL
pmid: 26506894
|
[4] |
Warnakulasuriya S . Global epidemiology of oral and oro-pharyngeal cancer[J]. Oral Oncol, 2009,45(4/5):309-316.
doi: 10.1016/j.oraloncology.2008.06.002
URL
pmid: 18804401
|
[5] |
Parkin DM, Läärä E, Muir CS . Estimates of the worldwide frequency of sixteen major cancers in 1980[J]. Int J Cancer, 1988,41(2):184-197.
doi: 10.1002/(ISSN)1097-0215
URL
|
[6] |
Liu W, Wang YF, Zhou HW , et al. Malignant transforma-tion of oral leukoplakia: a retrospective cohort study of 218 Chinese patients[J]. BMC Cancer, 2010,10:685.
doi: 10.1186/1471-2407-10-685
URL
pmid: 3009685
|
[7] |
Jia YL, Xu M, Dou CW , et al. P300/CBP-associated factor (PCAF) inhibits the growth of hepatocellular carcinoma by promoting cell autophagy[J]. Cell Death Dis, 2016,7(10):e2400.
doi: 10.1038/cddis.2016.247
URL
pmid: 27711074
|
[8] |
Altman BJ, Jacobs SR, Mason EF , et al. Autophagy is essen-tial to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis[J]. Oncogene, 2011,30(16):1855-1867.
doi: 10.1038/onc.2010.561
URL
pmid: 21151168
|
[9] |
Wei H, Wei S, Gan B , et al. Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis[J]. Genes Dev, 2011,25(14):1510-1527.
doi: 10.4161/auto.8.1.18171
URL
pmid: 21764854
|
[10] |
Chen HY, White E . Role of autophagy in cancer prevention[J]. Cancer Prev Res(Phila), 2011,4(7):973-983.
doi: 10.1158/1940-6207.CAPR-10-0387
URL
pmid: 3136921
|
[11] |
Mathew R, Karp CM, Beaudoin B , et al. Autophagy sup-presses tumorigenesis through elimination of p62[J]. Cell, 2009,137(6):1062-1075.
doi: 10.1016/j.cell.2009.03.048
URL
pmid: 2802318
|
[12] |
Kubisch J, Türei D, Földvári-Nagy L , et al. Complex regu-lation of autophagy in cancer-integrated approaches to discover the networks that hold a double-edged sword[J]. Semin Cancer Biol, 2013,23(4):252-261.
doi: 10.1016/j.semcancer.2013.06.009
URL
pmid: 23810837
|
[13] |
Li Q, Gu C, Zhu Y , et al. Polymorphisms in the m TOR gene and risk of sporadic prostate cancer in an Eastern Chinese population[J]. PLoS One, 2013,8(8):e71968.
doi: 10.1371/journal.pone.0071968
URL
pmid: 3882253
|
[14] |
Roy B, Pattanaik AK, Das J , et al. Role of PI3K/Akt/mTOR and MEK/ERK pathway in Concanavalin A induced auto-phagy in HeLa cells[J]. Chem Biol Interact, 2014,210:96-102.
doi: 10.1016/j.cbi.2014.01.003
URL
pmid: 24434245
|
[15] |
Zhu W, Pan X, Li F , et al. Expression of Beclin 1 and LC3 in FIGO stage Ⅰ-Ⅱ cervical squamous cell carcinoma and relationship to survival[J]. Tumour Biol, 2012,33(5):1653-1659.
doi: 10.1007/s13277-012-0421-4
URL
pmid: 22648564
|
[16] |
Jiang ZF, Shao LJ, Wang WM , et al. Decreased expression of Beclin-1 and LC3 in human lung cancer[J]. Mol Biol Rep, 2012,39(1):259-267.
doi: 10.1007/s11033-011-0734-1
URL
pmid: 21556768
|
[17] |
Liu JL, Chen FF, Lung J , et al. Prognostic significance of p62/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma[J]. Br J Cancer, 2014,111(5):944-954.
doi: 10.1038/bjc.2014.355
URL
pmid: 24983366
|
[18] |
Wu DH, Wang TT, Ruan DY , et al. Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma[J]. Biomed Pharmacother, 2018,97:195-202.
doi: 10.1016/j.biopha.2017.10.025
URL
|
[19] |
Zou Y, Ge M, Wang X . Targeting PI3K-AKT-mTOR by LY3023414 inhibits human skin squamous cell carcinoma cell growth in vitro and in vivo[J]. Biochem Biophys Res Commun, 2017,490(2):385-392.
doi: 10.1016/j.bbrc.2017.06.052
URL
pmid: 28623128
|
[20] |
Molinolo AA, Hewitt SM, Amornphimoltham P , et al. Dis-secting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative[J]. Clin Cancer Res, 2007,13(17):4964-4973.
doi: 10.1158/1078-0432.CCR-07-1041
URL
pmid: 17785546
|
[21] |
Liu Y, Hidayat S, Su WH , et al. Expression and activity of mTOR and its substrates in different cell cycle phases and in oral squamous cell carcinomas of different malignant grade[J]. Cell Biochem Funct, 2007,25(1):45-53.
doi: 10.1002/cbf.1332
URL
pmid: 16927414
|
[22] |
时艳辉 . 自噬相关基因mTOR和MAP1LC3B与乳腺癌发生发展关系的研究[D]. 济南: 山东师范大学, 2017.
|
|
Shi YH . Study on relationship between mTOR and MAP1-LC3B and the development of breast cancer[D]. Jinan: Shan-dong Normal University, 2017.
|
[23] |
张晶, 舒丽莎, 陈江平 , 等. Beclin1、MAP1LC3B和mTOR在宫颈病变中的表达及临床意义[J]. 河北北方学院学报(自然科学版), 2017,33(6):1-5.
|
|
Zhang J, Shu LS, Chen JP , et al. Expression of Beclin1, MAP1LC3B and mTOR and their clinical significance in cervical lesions[J]. J Hebei North Univ (Nat Sci Ed), 2017,33(6):1-5.
|
[24] |
吴淑华, 胡金龙, 何双 , 等. 大肠癌中Beclin1、LC3和mTOR的表达及意义[J]. 临床实验与病理学杂志, 2014,30(12):1333-1338.
doi: 10.13315/j.cnki.cjcep.2014.12.002
URL
|
|
Wu SH, Hu JL, He S , et al. Expression of Beclin1, LC3 and mTOR and their significance in colorectal carcinoma[J]. J Clin Exp Pathol, 2014,30(12):1333-1338.
doi: 10.13315/j.cnki.cjcep.2014.12.002
URL
|